Kyverna Therapeutics, Inc. Common Stock (NASDAQ: KYTX) last traded at $6.39, up 3.40% on the session. The quote above updates while this page is open; the figures below are drawn from Kyverna Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kyverna Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker KYTX. Its market capitalisation is $395.18 million.
Valuation measures for Kyverna Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $395.18M |
|---|---|
| Enterprise value | $417.65M |
| Price / book | 2.39 |
| Beta | 2.29 |
Trailing-twelve-month figures tagged in Kyverna Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$152.64M |
| EPS (TTM) | -$2.93 |
|---|
| Return on equity | -92.20% |
|---|
| Cash | $31.81M |
|---|
Range and volume for KYTX over the past 52 weeks.
| 52-week high | $13.67 |
|---|---|
| 52-week low | $5.96 |
| Volume | 876.4K |
| Average volume | 903.4K |
| Previous close | $6.18 |
Invest a chosen dollar amount in Kyverna Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KYTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.